Article

ForbesForbes on 2019-10-23 14:23

How Bempegaldesleukin Woes Have Impacted Nektar Therapeutics

Nektar Therapeutics (NASDAQ: NKTR), a biopharmaceutical company based in San Francisco, is focused on discovering and developing medicines in areas ...

Related news